Fecal Microbiota Transplantation (FMT) Combined With Calorie-Restricted Diet and Semaglutide in Patients With Obesity and Type 2 Diabetes

Investigation of the efficacy of fecal microbiota transplantation added to calorie-restricted diet and semaglutide versus calorie-restricted diet and semaglutide alone for weight loss and metabolic improvement in patients with moderate to severe obesity and type 2 diabetes mellitus.

NCT Number	NCT07599046
Lead Sponsor	Eighth Affiliated Hospital, Sun Yat-sen University
Conditions	Obesity Type 2 Diabetes Mellitus
Enrollment	20 participants
Start Date	2026-04-30
Primary Completion	2027-01-30 (estimated)
Study Completion	2029-12-30 (estimated)
Updated on ClinicalTrials.gov	2026-05-20